Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E Liu(The University of Texas MD Anderson Cancer Center), Yijiu Tong(The University of Texas MD Anderson Cancer Center), Gianpietro Dotti(University of North Carolina at Chapel Hill), Hila Shaim(The University of Texas MD Anderson Cancer Center), Barbara Savoldo(University of North Carolina at Chapel Hill), Malini Mukherjee(Baylor College of Medicine), Jordan S. Orange(Baylor College of Medicine), Xiaochun Wan(The University of Texas MD Anderson Cancer Center), Xinyan Lu(The University of Texas MD Anderson Cancer Center), Alex Reynolds(The University of Texas MD Anderson Cancer Center), Mihai Gagea(The University of Texas MD Anderson Cancer Center), Pinaki P. Banerjee(The University of Texas MD Anderson Cancer Center), Rong Cai(The University of Texas MD Anderson Cancer Center), Mustafa Bdaiwi(The University of Texas MD Anderson Cancer Center), Rafet Başar(The University of Texas MD Anderson Cancer Center), Muharrem Müftüoğlu(The University of Texas MD Anderson Cancer Center), Lin Li(The University of Texas MD Anderson Cancer Center), David Marín(The University of Texas MD Anderson Cancer Center), William G. Wierda(The University of Texas MD Anderson Cancer Center), Michael J. Keating(The University of Texas MD Anderson Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center)
Cited by 806